K001118

Substantially Equivalent

MODIFICATION TO LIPOPROTEIN (A) SPQ III ANTIBODY REAGENT SET

Applicant: DiaSorin, Inc.
Product code: DFC
Advisory panel: Immunology
Date received: 2000-04-07
Decision date: 2000-04-25
Decision: Substantially Equivalent
Clearance type: Special
Location: Ellicott City, MD, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.